nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP3A4—breast cancer	0.106	0.546	CbGaD
Bromocriptine—ABCB1—breast cancer	0.0885	0.454	CbGaD
Bromocriptine—HTR6—Raloxifene—breast cancer	0.069	0.151	CbGbCtD
Bromocriptine—HTR2B—Raloxifene—breast cancer	0.0616	0.135	CbGbCtD
Bromocriptine—CYP1A2—Anastrozole—breast cancer	0.0289	0.0632	CbGbCtD
Bromocriptine—CYP1A2—Toremifene—breast cancer	0.0264	0.0578	CbGbCtD
Bromocriptine—ABCB1—Toremifene—breast cancer	0.0231	0.0506	CbGbCtD
Bromocriptine—CYP3A4—Exemestane—breast cancer	0.02	0.0437	CbGbCtD
Bromocriptine—CYP3A4—Letrozole—breast cancer	0.017	0.0372	CbGbCtD
Bromocriptine—ABCB1—Lapatinib—breast cancer	0.0168	0.0369	CbGbCtD
Bromocriptine—CYP3A4—Anastrozole—breast cancer	0.0151	0.0331	CbGbCtD
Bromocriptine—CYP3A4—Toremifene—breast cancer	0.0138	0.0303	CbGbCtD
Bromocriptine—CYP3A4—Fulvestrant—breast cancer	0.0129	0.0282	CbGbCtD
Bromocriptine—CYP3A4—Thiotepa—breast cancer	0.0115	0.0251	CbGbCtD
Bromocriptine—CYP3A4—Ixabepilone—breast cancer	0.0105	0.023	CbGbCtD
Bromocriptine—CYP3A4—Lapatinib—breast cancer	0.0101	0.0221	CbGbCtD
Bromocriptine—CYP1A2—Tamoxifen—breast cancer	0.00964	0.0211	CbGbCtD
Bromocriptine—ABCB1—Vinorelbine—breast cancer	0.00934	0.0205	CbGbCtD
Bromocriptine—ABCB1—Tamoxifen—breast cancer	0.00843	0.0185	CbGbCtD
Bromocriptine—ABCB1—Mitoxantrone—breast cancer	0.00823	0.018	CbGbCtD
Bromocriptine—CYP3A4—Raloxifene—breast cancer	0.00765	0.0167	CbGbCtD
Bromocriptine—ABCB1—Gemcitabine—breast cancer	0.00727	0.0159	CbGbCtD
Bromocriptine—CYP1A2—Fluorouracil—breast cancer	0.00711	0.0156	CbGbCtD
Bromocriptine—ABCB1—Paclitaxel—breast cancer	0.00656	0.0144	CbGbCtD
Bromocriptine—ABCB1—Irinotecan—breast cancer	0.00648	0.0142	CbGbCtD
Bromocriptine—ABCB1—Vinblastine—breast cancer	0.00576	0.0126	CbGbCtD
Bromocriptine—CYP3A4—Vinorelbine—breast cancer	0.0056	0.0123	CbGbCtD
Bromocriptine—CYP3A4—Tamoxifen—breast cancer	0.00505	0.0111	CbGbCtD
Bromocriptine—CYP3A4—Mitoxantrone—breast cancer	0.00493	0.0108	CbGbCtD
Bromocriptine—ABCB1—Docetaxel—breast cancer	0.00475	0.0104	CbGbCtD
Bromocriptine—CYP3A4—Paclitaxel—breast cancer	0.00393	0.00861	CbGbCtD
Bromocriptine—CYP3A4—Irinotecan—breast cancer	0.00388	0.0085	CbGbCtD
Bromocriptine—ABCB1—Doxorubicin—breast cancer	0.00354	0.00775	CbGbCtD
Bromocriptine—CYP3A4—Vinblastine—breast cancer	0.00345	0.00755	CbGbCtD
Bromocriptine—ABCB1—Methotrexate—breast cancer	0.00343	0.00751	CbGbCtD
Bromocriptine—CYP3A4—Docetaxel—breast cancer	0.00284	0.00623	CbGbCtD
Bromocriptine—CYP3A4—Doxorubicin—breast cancer	0.00212	0.00464	CbGbCtD
Bromocriptine—ADRA1D—epithelium—breast cancer	0.000549	0.0327	CbGeAlD
Bromocriptine—DRD5—female reproductive system—breast cancer	0.000509	0.0303	CbGeAlD
Bromocriptine—Ergoloid mesylate—CYP3A4—breast cancer	0.000502	0.201	CrCbGaD
Bromocriptine—DRD5—female gonad—breast cancer	0.000463	0.0276	CbGeAlD
Bromocriptine—ADRA2C—nipple—breast cancer	0.000446	0.0266	CbGeAlD
Bromocriptine—DRD5—endocrine gland—breast cancer	0.000431	0.0256	CbGeAlD
Bromocriptine—ADRA1D—female reproductive system—breast cancer	0.000408	0.0243	CbGeAlD
Bromocriptine—CYP1A2—nipple—breast cancer	0.000387	0.0231	CbGeAlD
Bromocriptine—Dihydroergotamine—CYP3A4—breast cancer	0.000381	0.152	CrCbGaD
Bromocriptine—HTR2B—skin of body—breast cancer	0.000363	0.0216	CbGeAlD
Bromocriptine—ADRA2A—nipple—breast cancer	0.000356	0.0212	CbGeAlD
Bromocriptine—Ergonovine—CYP3A4—breast cancer	0.000348	0.139	CrCbGaD
Bromocriptine—ADRA1D—endocrine gland—breast cancer	0.000345	0.0206	CbGeAlD
Bromocriptine—HTR2B—endometrium—breast cancer	0.000342	0.0204	CbGeAlD
Bromocriptine—HTR7—epithelium—breast cancer	0.000327	0.0195	CbGeAlD
Bromocriptine—ADRB1—adipose tissue—breast cancer	0.000322	0.0192	CbGeAlD
Bromocriptine—Dihydroergotamine—ABCB1—breast cancer	0.000317	0.127	CrCbGaD
Bromocriptine—HTR2B—uterus—breast cancer	0.000316	0.0188	CbGeAlD
Bromocriptine—ADRA1A—epithelium—breast cancer	0.000315	0.0188	CbGeAlD
Bromocriptine—HTR1B—female reproductive system—breast cancer	0.000315	0.0188	CbGeAlD
Bromocriptine—HTR2B—adipose tissue—breast cancer	0.000309	0.0184	CbGeAlD
Bromocriptine—HTR1D—female reproductive system—breast cancer	0.000305	0.0182	CbGeAlD
Bromocriptine—Methylergometrine—CYP3A4—breast cancer	0.000304	0.122	CrCbGaD
Bromocriptine—HTR2C—female reproductive system—breast cancer	0.000302	0.018	CbGeAlD
Bromocriptine—ADRB1—female reproductive system—breast cancer	0.000296	0.0177	CbGeAlD
Bromocriptine—Ergonovine—ABCB1—breast cancer	0.00029	0.116	CrCbGaD
Bromocriptine—HTR2B—female reproductive system—breast cancer	0.000284	0.0169	CbGeAlD
Bromocriptine—HTR2B—adrenal gland—breast cancer	0.000277	0.0165	CbGeAlD
Bromocriptine—ADRA2C—endometrium—breast cancer	0.00027	0.0161	CbGeAlD
Bromocriptine—HTR1B—endocrine gland—breast cancer	0.000267	0.0159	CbGeAlD
Bromocriptine—ADRA1A—adipose tissue—breast cancer	0.000255	0.0152	CbGeAlD
Bromocriptine—DRD2—pituitary gland—breast cancer	0.000251	0.0149	CbGeAlD
Bromocriptine—ADRB1—endocrine gland—breast cancer	0.000251	0.0149	CbGeAlD
Bromocriptine—HTR2A—embryo—breast cancer	0.00025	0.0149	CbGeAlD
Bromocriptine—ADRA2C—uterus—breast cancer	0.000248	0.0148	CbGeAlD
Bromocriptine—HTR1A—adrenal gland—breast cancer	0.000248	0.0148	CbGeAlD
Bromocriptine—ADRA2C—pituitary gland—breast cancer	0.000244	0.0145	CbGeAlD
Bromocriptine—HTR7—female reproductive system—breast cancer	0.000243	0.0145	CbGeAlD
Bromocriptine—ADRA2C—adipose tissue—breast cancer	0.000243	0.0145	CbGeAlD
Bromocriptine—HTR7—adrenal gland—breast cancer	0.000237	0.0141	CbGeAlD
Bromocriptine—ADRA1A—adrenal gland—breast cancer	0.000229	0.0136	CbGeAlD
Bromocriptine—ADRA2C—adrenal gland—breast cancer	0.000218	0.013	CbGeAlD
Bromocriptine—HTR1A—endocrine gland—breast cancer	0.000215	0.0128	CbGeAlD
Bromocriptine—ADRA2A—endometrium—breast cancer	0.000215	0.0128	CbGeAlD
Bromocriptine—HTR7—endocrine gland—breast cancer	0.000206	0.0122	CbGeAlD
Bromocriptine—HTR2A—epithelium—breast cancer	0.000204	0.0121	CbGeAlD
Bromocriptine—ADRA2C—female gonad—breast cancer	0.000203	0.0121	CbGeAlD
Bromocriptine—ADRA1A—endocrine gland—breast cancer	0.000198	0.0118	CbGeAlD
Bromocriptine—ADRA2A—uterus—breast cancer	0.000198	0.0118	CbGeAlD
Bromocriptine—Ergotamine—CYP3A4—breast cancer	0.000196	0.0784	CrCbGaD
Bromocriptine—ADRA2A—pituitary gland—breast cancer	0.000195	0.0116	CbGeAlD
Bromocriptine—DRD2—endocrine gland—breast cancer	0.000194	0.0116	CbGeAlD
Bromocriptine—ADRA2A—adipose tissue—breast cancer	0.000194	0.0115	CbGeAlD
Bromocriptine—ADRA2A—female reproductive system—breast cancer	0.000178	0.0106	CbGeAlD
Bromocriptine—ADRA2A—adrenal gland—breast cancer	0.000174	0.0104	CbGeAlD
Bromocriptine—HTR2B—lymph node—breast cancer	0.000166	0.00988	CbGeAlD
Bromocriptine—HTR2A—pituitary gland—breast cancer	0.000165	0.00986	CbGeAlD
Bromocriptine—CYP1A2—endocrine gland—breast cancer	0.000164	0.00977	CbGeAlD
Bromocriptine—ABCB1—embryo—breast cancer	0.000164	0.00975	CbGeAlD
Bromocriptine—Ergotamine—ABCB1—breast cancer	0.000163	0.0653	CrCbGaD
Bromocriptine—ADRA2A—female gonad—breast cancer	0.000162	0.00966	CbGeAlD
Bromocriptine—HTR2A—female reproductive system—breast cancer	0.000151	0.00902	CbGeAlD
Bromocriptine—ADRA2A—endocrine gland—breast cancer	0.000151	0.00898	CbGeAlD
Bromocriptine—HTR2A—adrenal gland—breast cancer	0.000148	0.00881	CbGeAlD
Bromocriptine—CYP3A4—female reproductive system—breast cancer	0.00014	0.00835	CbGeAlD
Bromocriptine—ABCB1—epithelium—breast cancer	0.000134	0.00796	CbGeAlD
Bromocriptine—ADRA2C—lymph node—breast cancer	0.000131	0.00778	CbGeAlD
Bromocriptine—HTR2A—endocrine gland—breast cancer	0.000128	0.00764	CbGeAlD
Bromocriptine—ABCB1—endometrium—breast cancer	0.00012	0.00714	CbGeAlD
Bromocriptine—CYP3A4—endocrine gland—breast cancer	0.000119	0.00707	CbGeAlD
Bromocriptine—ABCB1—uterus—breast cancer	0.00011	0.00658	CbGeAlD
Bromocriptine—ABCB1—pituitary gland—breast cancer	0.000108	0.00646	CbGeAlD
Bromocriptine—ABCB1—adipose tissue—breast cancer	0.000108	0.00643	CbGeAlD
Bromocriptine—ADRA2A—lymph node—breast cancer	0.000104	0.00621	CbGeAlD
Bromocriptine—ABCB1—female reproductive system—breast cancer	9.93e-05	0.00591	CbGeAlD
Bromocriptine—ABCB1—adrenal gland—breast cancer	9.69e-05	0.00577	CbGeAlD
Bromocriptine—ABCB1—bone marrow—breast cancer	9.37e-05	0.00558	CbGeAlD
Bromocriptine—ABCB1—female gonad—breast cancer	9.03e-05	0.00538	CbGeAlD
Bromocriptine—ABCB1—endocrine gland—breast cancer	8.4e-05	0.005	CbGeAlD
Bromocriptine—Confusional state—Capecitabine—breast cancer	6.33e-05	0.00031	CcSEcCtD
Bromocriptine—Tachycardia—Docetaxel—breast cancer	6.32e-05	0.000309	CcSEcCtD
Bromocriptine—Feeling abnormal—Paclitaxel—breast cancer	6.3e-05	0.000308	CcSEcCtD
Bromocriptine—Skin disorder—Docetaxel—breast cancer	6.29e-05	0.000308	CcSEcCtD
Bromocriptine—Oedema—Capecitabine—breast cancer	6.27e-05	0.000307	CcSEcCtD
Bromocriptine—Bradycardia—Epirubicin—breast cancer	6.26e-05	0.000306	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Paclitaxel—breast cancer	6.25e-05	0.000306	CcSEcCtD
Bromocriptine—Diarrhoea—Gemcitabine—breast cancer	6.25e-05	0.000306	CcSEcCtD
Bromocriptine—Infection—Capecitabine—breast cancer	6.23e-05	0.000305	CcSEcCtD
Bromocriptine—Dizziness—Irinotecan—breast cancer	6.2e-05	0.000303	CcSEcCtD
Bromocriptine—Anorexia—Docetaxel—breast cancer	6.18e-05	0.000302	CcSEcCtD
Bromocriptine—Shock—Capecitabine—breast cancer	6.17e-05	0.000302	CcSEcCtD
Bromocriptine—Rhinitis—Epirubicin—breast cancer	6.17e-05	0.000302	CcSEcCtD
Bromocriptine—Nervous system disorder—Capecitabine—breast cancer	6.15e-05	0.000301	CcSEcCtD
Bromocriptine—Eye disorder—Methotrexate—breast cancer	6.14e-05	0.000301	CcSEcCtD
Bromocriptine—Diarrhoea—Fluorouracil—breast cancer	6.14e-05	0.000301	CcSEcCtD
Bromocriptine—Tinnitus—Methotrexate—breast cancer	6.13e-05	0.0003	CcSEcCtD
Bromocriptine—Tachycardia—Capecitabine—breast cancer	6.12e-05	0.0003	CcSEcCtD
Bromocriptine—Hypoaesthesia—Epirubicin—breast cancer	6.12e-05	0.000299	CcSEcCtD
Bromocriptine—Cardiac disorder—Methotrexate—breast cancer	6.1e-05	0.000299	CcSEcCtD
Bromocriptine—Skin disorder—Capecitabine—breast cancer	6.09e-05	0.000298	CcSEcCtD
Bromocriptine—Urticaria—Paclitaxel—breast cancer	6.07e-05	0.000297	CcSEcCtD
Bromocriptine—Oedema peripheral—Epirubicin—breast cancer	6.06e-05	0.000297	CcSEcCtD
Bromocriptine—Hypotension—Docetaxel—breast cancer	6.06e-05	0.000296	CcSEcCtD
Bromocriptine—Connective tissue disorder—Epirubicin—breast cancer	6.05e-05	0.000296	CcSEcCtD
Bromocriptine—Abdominal pain—Paclitaxel—breast cancer	6.04e-05	0.000296	CcSEcCtD
Bromocriptine—Body temperature increased—Paclitaxel—breast cancer	6.04e-05	0.000296	CcSEcCtD
Bromocriptine—Anorexia—Capecitabine—breast cancer	5.98e-05	0.000293	CcSEcCtD
Bromocriptine—Angiopathy—Methotrexate—breast cancer	5.96e-05	0.000292	CcSEcCtD
Bromocriptine—Vomiting—Mitoxantrone—breast cancer	5.96e-05	0.000292	CcSEcCtD
Bromocriptine—Vomiting—Irinotecan—breast cancer	5.96e-05	0.000292	CcSEcCtD
Bromocriptine—Sinusitis—Doxorubicin—breast cancer	5.95e-05	0.000291	CcSEcCtD
Bromocriptine—Dizziness—Fluorouracil—breast cancer	5.94e-05	0.00029	CcSEcCtD
Bromocriptine—Visual impairment—Epirubicin—breast cancer	5.93e-05	0.00029	CcSEcCtD
Bromocriptine—Mediastinal disorder—Methotrexate—breast cancer	5.92e-05	0.00029	CcSEcCtD
Bromocriptine—Rash—Irinotecan—breast cancer	5.91e-05	0.000289	CcSEcCtD
Bromocriptine—Rash—Mitoxantrone—breast cancer	5.91e-05	0.000289	CcSEcCtD
Bromocriptine—Dermatitis—Mitoxantrone—breast cancer	5.91e-05	0.000289	CcSEcCtD
Bromocriptine—Dermatitis—Irinotecan—breast cancer	5.91e-05	0.000289	CcSEcCtD
Bromocriptine—Headache—Irinotecan—breast cancer	5.87e-05	0.000287	CcSEcCtD
Bromocriptine—Headache—Mitoxantrone—breast cancer	5.87e-05	0.000287	CcSEcCtD
Bromocriptine—Hypotension—Capecitabine—breast cancer	5.86e-05	0.000287	CcSEcCtD
Bromocriptine—Insomnia—Docetaxel—breast cancer	5.86e-05	0.000287	CcSEcCtD
Bromocriptine—Paraesthesia—Docetaxel—breast cancer	5.82e-05	0.000285	CcSEcCtD
Bromocriptine—Alopecia—Methotrexate—breast cancer	5.81e-05	0.000284	CcSEcCtD
Bromocriptine—ABCB1—lymph node—breast cancer	5.81e-05	0.00346	CbGeAlD
Bromocriptine—Vomiting—Gemcitabine—breast cancer	5.81e-05	0.000284	CcSEcCtD
Bromocriptine—Bradycardia—Doxorubicin—breast cancer	5.8e-05	0.000284	CcSEcCtD
Bromocriptine—Dyspnoea—Docetaxel—breast cancer	5.78e-05	0.000283	CcSEcCtD
Bromocriptine—Somnolence—Docetaxel—breast cancer	5.76e-05	0.000282	CcSEcCtD
Bromocriptine—Mental disorder—Methotrexate—breast cancer	5.76e-05	0.000282	CcSEcCtD
Bromocriptine—Rash—Gemcitabine—breast cancer	5.76e-05	0.000282	CcSEcCtD
Bromocriptine—Dermatitis—Gemcitabine—breast cancer	5.75e-05	0.000281	CcSEcCtD
Bromocriptine—Eye disorder—Epirubicin—breast cancer	5.75e-05	0.000281	CcSEcCtD
Bromocriptine—Tinnitus—Epirubicin—breast cancer	5.74e-05	0.000281	CcSEcCtD
Bromocriptine—Headache—Gemcitabine—breast cancer	5.72e-05	0.00028	CcSEcCtD
Bromocriptine—Cardiac disorder—Epirubicin—breast cancer	5.71e-05	0.000279	CcSEcCtD
Bromocriptine—Vomiting—Fluorouracil—breast cancer	5.71e-05	0.000279	CcSEcCtD
Bromocriptine—Rhinitis—Doxorubicin—breast cancer	5.71e-05	0.000279	CcSEcCtD
Bromocriptine—Dyspepsia—Docetaxel—breast cancer	5.7e-05	0.000279	CcSEcCtD
Bromocriptine—Insomnia—Capecitabine—breast cancer	5.67e-05	0.000278	CcSEcCtD
Bromocriptine—Hypoaesthesia—Doxorubicin—breast cancer	5.66e-05	0.000277	CcSEcCtD
Bromocriptine—Rash—Fluorouracil—breast cancer	5.66e-05	0.000277	CcSEcCtD
Bromocriptine—Dermatitis—Fluorouracil—breast cancer	5.66e-05	0.000277	CcSEcCtD
Bromocriptine—Paraesthesia—Capecitabine—breast cancer	5.63e-05	0.000276	CcSEcCtD
Bromocriptine—Decreased appetite—Docetaxel—breast cancer	5.63e-05	0.000276	CcSEcCtD
Bromocriptine—Headache—Fluorouracil—breast cancer	5.62e-05	0.000275	CcSEcCtD
Bromocriptine—Oedema peripheral—Doxorubicin—breast cancer	5.61e-05	0.000274	CcSEcCtD
Bromocriptine—Dysgeusia—Methotrexate—breast cancer	5.6e-05	0.000274	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Docetaxel—breast cancer	5.59e-05	0.000274	CcSEcCtD
Bromocriptine—Connective tissue disorder—Doxorubicin—breast cancer	5.59e-05	0.000274	CcSEcCtD
Bromocriptine—Dyspnoea—Capecitabine—breast cancer	5.59e-05	0.000274	CcSEcCtD
Bromocriptine—Fatigue—Docetaxel—breast cancer	5.59e-05	0.000273	CcSEcCtD
Bromocriptine—Angiopathy—Epirubicin—breast cancer	5.58e-05	0.000273	CcSEcCtD
Bromocriptine—Nausea—Irinotecan—breast cancer	5.57e-05	0.000272	CcSEcCtD
Bromocriptine—Nausea—Mitoxantrone—breast cancer	5.57e-05	0.000272	CcSEcCtD
Bromocriptine—Mediastinal disorder—Epirubicin—breast cancer	5.54e-05	0.000271	CcSEcCtD
Bromocriptine—Constipation—Docetaxel—breast cancer	5.54e-05	0.000271	CcSEcCtD
Bromocriptine—Dyspepsia—Capecitabine—breast cancer	5.52e-05	0.00027	CcSEcCtD
Bromocriptine—Arrhythmia—Epirubicin—breast cancer	5.5e-05	0.000269	CcSEcCtD
Bromocriptine—Visual impairment—Doxorubicin—breast cancer	5.49e-05	0.000268	CcSEcCtD
Bromocriptine—Asthenia—Paclitaxel—breast cancer	5.49e-05	0.000268	CcSEcCtD
Bromocriptine—Decreased appetite—Capecitabine—breast cancer	5.45e-05	0.000267	CcSEcCtD
Bromocriptine—Alopecia—Epirubicin—breast cancer	5.44e-05	0.000266	CcSEcCtD
Bromocriptine—Nausea—Gemcitabine—breast cancer	5.42e-05	0.000265	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Capecitabine—breast cancer	5.42e-05	0.000265	CcSEcCtD
Bromocriptine—Fatigue—Capecitabine—breast cancer	5.41e-05	0.000265	CcSEcCtD
Bromocriptine—Vision blurred—Methotrexate—breast cancer	5.39e-05	0.000264	CcSEcCtD
Bromocriptine—Mental disorder—Epirubicin—breast cancer	5.39e-05	0.000264	CcSEcCtD
Bromocriptine—Constipation—Capecitabine—breast cancer	5.37e-05	0.000262	CcSEcCtD
Bromocriptine—Feeling abnormal—Docetaxel—breast cancer	5.34e-05	0.000261	CcSEcCtD
Bromocriptine—Nausea—Fluorouracil—breast cancer	5.33e-05	0.000261	CcSEcCtD
Bromocriptine—Eye disorder—Doxorubicin—breast cancer	5.32e-05	0.00026	CcSEcCtD
Bromocriptine—Tinnitus—Doxorubicin—breast cancer	5.31e-05	0.00026	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Docetaxel—breast cancer	5.3e-05	0.000259	CcSEcCtD
Bromocriptine—Cardiac disorder—Doxorubicin—breast cancer	5.28e-05	0.000258	CcSEcCtD
Bromocriptine—Tension—Epirubicin—breast cancer	5.26e-05	0.000257	CcSEcCtD
Bromocriptine—Dysgeusia—Epirubicin—breast cancer	5.24e-05	0.000257	CcSEcCtD
Bromocriptine—Diarrhoea—Paclitaxel—breast cancer	5.23e-05	0.000256	CcSEcCtD
Bromocriptine—Nervousness—Epirubicin—breast cancer	5.2e-05	0.000254	CcSEcCtD
Bromocriptine—Feeling abnormal—Capecitabine—breast cancer	5.17e-05	0.000253	CcSEcCtD
Bromocriptine—Angiopathy—Doxorubicin—breast cancer	5.16e-05	0.000253	CcSEcCtD
Bromocriptine—Muscle spasms—Epirubicin—breast cancer	5.15e-05	0.000252	CcSEcCtD
Bromocriptine—Vertigo—Methotrexate—breast cancer	5.14e-05	0.000252	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Capecitabine—breast cancer	5.13e-05	0.000251	CcSEcCtD
Bromocriptine—Mediastinal disorder—Doxorubicin—breast cancer	5.13e-05	0.000251	CcSEcCtD
Bromocriptine—Abdominal pain—Docetaxel—breast cancer	5.12e-05	0.000251	CcSEcCtD
Bromocriptine—Body temperature increased—Docetaxel—breast cancer	5.12e-05	0.000251	CcSEcCtD
Bromocriptine—Arrhythmia—Doxorubicin—breast cancer	5.09e-05	0.000249	CcSEcCtD
Bromocriptine—Dizziness—Paclitaxel—breast cancer	5.06e-05	0.000247	CcSEcCtD
Bromocriptine—Vision blurred—Epirubicin—breast cancer	5.05e-05	0.000247	CcSEcCtD
Bromocriptine—Alopecia—Doxorubicin—breast cancer	5.03e-05	0.000246	CcSEcCtD
Bromocriptine—Mental disorder—Doxorubicin—breast cancer	4.99e-05	0.000244	CcSEcCtD
Bromocriptine—Urticaria—Capecitabine—breast cancer	4.98e-05	0.000244	CcSEcCtD
Bromocriptine—Body temperature increased—Capecitabine—breast cancer	4.96e-05	0.000243	CcSEcCtD
Bromocriptine—Abdominal pain—Capecitabine—breast cancer	4.96e-05	0.000243	CcSEcCtD
Bromocriptine—Convulsion—Methotrexate—breast cancer	4.96e-05	0.000243	CcSEcCtD
Bromocriptine—Agitation—Epirubicin—breast cancer	4.92e-05	0.000241	CcSEcCtD
Bromocriptine—Tension—Doxorubicin—breast cancer	4.86e-05	0.000238	CcSEcCtD
Bromocriptine—Vomiting—Paclitaxel—breast cancer	4.86e-05	0.000238	CcSEcCtD
Bromocriptine—Dysgeusia—Doxorubicin—breast cancer	4.85e-05	0.000237	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.84e-05	0.000237	CcSEcCtD
Bromocriptine—Rash—Paclitaxel—breast cancer	4.82e-05	0.000236	CcSEcCtD
Bromocriptine—Dermatitis—Paclitaxel—breast cancer	4.82e-05	0.000236	CcSEcCtD
Bromocriptine—Nervousness—Doxorubicin—breast cancer	4.81e-05	0.000235	CcSEcCtD
Bromocriptine—Vertigo—Epirubicin—breast cancer	4.81e-05	0.000235	CcSEcCtD
Bromocriptine—Syncope—Epirubicin—breast cancer	4.8e-05	0.000235	CcSEcCtD
Bromocriptine—Headache—Paclitaxel—breast cancer	4.79e-05	0.000234	CcSEcCtD
Bromocriptine—Muscle spasms—Doxorubicin—breast cancer	4.76e-05	0.000233	CcSEcCtD
Bromocriptine—Confusional state—Methotrexate—breast cancer	4.71e-05	0.00023	CcSEcCtD
Bromocriptine—Loss of consciousness—Epirubicin—breast cancer	4.71e-05	0.00023	CcSEcCtD
Bromocriptine—Vision blurred—Doxorubicin—breast cancer	4.67e-05	0.000228	CcSEcCtD
Bromocriptine—Asthenia—Docetaxel—breast cancer	4.65e-05	0.000227	CcSEcCtD
Bromocriptine—Convulsion—Epirubicin—breast cancer	4.64e-05	0.000227	CcSEcCtD
Bromocriptine—Infection—Methotrexate—breast cancer	4.64e-05	0.000227	CcSEcCtD
Bromocriptine—Hypertension—Epirubicin—breast cancer	4.62e-05	0.000226	CcSEcCtD
Bromocriptine—Nervous system disorder—Methotrexate—breast cancer	4.58e-05	0.000224	CcSEcCtD
Bromocriptine—Agitation—Doxorubicin—breast cancer	4.55e-05	0.000223	CcSEcCtD
Bromocriptine—Anxiety—Epirubicin—breast cancer	4.54e-05	0.000222	CcSEcCtD
Bromocriptine—Nausea—Paclitaxel—breast cancer	4.54e-05	0.000222	CcSEcCtD
Bromocriptine—Skin disorder—Methotrexate—breast cancer	4.54e-05	0.000222	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.53e-05	0.000222	CcSEcCtD
Bromocriptine—Asthenia—Capecitabine—breast cancer	4.5e-05	0.00022	CcSEcCtD
Bromocriptine—Dry mouth—Epirubicin—breast cancer	4.46e-05	0.000218	CcSEcCtD
Bromocriptine—Vertigo—Doxorubicin—breast cancer	4.45e-05	0.000218	CcSEcCtD
Bromocriptine—Anorexia—Methotrexate—breast cancer	4.45e-05	0.000218	CcSEcCtD
Bromocriptine—Syncope—Doxorubicin—breast cancer	4.44e-05	0.000217	CcSEcCtD
Bromocriptine—Diarrhoea—Docetaxel—breast cancer	4.43e-05	0.000217	CcSEcCtD
Bromocriptine—Confusional state—Epirubicin—breast cancer	4.41e-05	0.000216	CcSEcCtD
Bromocriptine—Oedema—Epirubicin—breast cancer	4.37e-05	0.000214	CcSEcCtD
Bromocriptine—Hypotension—Methotrexate—breast cancer	4.36e-05	0.000214	CcSEcCtD
Bromocriptine—Loss of consciousness—Doxorubicin—breast cancer	4.36e-05	0.000213	CcSEcCtD
Bromocriptine—Infection—Epirubicin—breast cancer	4.34e-05	0.000212	CcSEcCtD
Bromocriptine—Shock—Epirubicin—breast cancer	4.3e-05	0.00021	CcSEcCtD
Bromocriptine—Convulsion—Doxorubicin—breast cancer	4.29e-05	0.00021	CcSEcCtD
Bromocriptine—Diarrhoea—Capecitabine—breast cancer	4.29e-05	0.00021	CcSEcCtD
Bromocriptine—Nervous system disorder—Epirubicin—breast cancer	4.29e-05	0.00021	CcSEcCtD
Bromocriptine—Dizziness—Docetaxel—breast cancer	4.29e-05	0.00021	CcSEcCtD
Bromocriptine—Hypertension—Doxorubicin—breast cancer	4.28e-05	0.000209	CcSEcCtD
Bromocriptine—Tachycardia—Epirubicin—breast cancer	4.27e-05	0.000209	CcSEcCtD
Bromocriptine—Skin disorder—Epirubicin—breast cancer	4.25e-05	0.000208	CcSEcCtD
Bromocriptine—Insomnia—Methotrexate—breast cancer	4.22e-05	0.000207	CcSEcCtD
Bromocriptine—Anxiety—Doxorubicin—breast cancer	4.2e-05	0.000206	CcSEcCtD
Bromocriptine—Paraesthesia—Methotrexate—breast cancer	4.19e-05	0.000205	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.19e-05	0.000205	CcSEcCtD
Bromocriptine—Anorexia—Epirubicin—breast cancer	4.17e-05	0.000204	CcSEcCtD
Bromocriptine—Dyspnoea—Methotrexate—breast cancer	4.16e-05	0.000204	CcSEcCtD
Bromocriptine—Somnolence—Methotrexate—breast cancer	4.15e-05	0.000203	CcSEcCtD
Bromocriptine—Dizziness—Capecitabine—breast cancer	4.15e-05	0.000203	CcSEcCtD
Bromocriptine—Dry mouth—Doxorubicin—breast cancer	4.13e-05	0.000202	CcSEcCtD
Bromocriptine—Vomiting—Docetaxel—breast cancer	4.12e-05	0.000202	CcSEcCtD
Bromocriptine—Dyspepsia—Methotrexate—breast cancer	4.11e-05	0.000201	CcSEcCtD
Bromocriptine—Rash—Docetaxel—breast cancer	4.09e-05	0.0002	CcSEcCtD
Bromocriptine—Hypotension—Epirubicin—breast cancer	4.08e-05	0.0002	CcSEcCtD
Bromocriptine—Dermatitis—Docetaxel—breast cancer	4.08e-05	0.0002	CcSEcCtD
Bromocriptine—Confusional state—Doxorubicin—breast cancer	4.08e-05	0.0002	CcSEcCtD
Bromocriptine—Decreased appetite—Methotrexate—breast cancer	4.06e-05	0.000199	CcSEcCtD
Bromocriptine—Headache—Docetaxel—breast cancer	4.06e-05	0.000199	CcSEcCtD
Bromocriptine—Oedema—Doxorubicin—breast cancer	4.04e-05	0.000198	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Methotrexate—breast cancer	4.03e-05	0.000197	CcSEcCtD
Bromocriptine—Fatigue—Methotrexate—breast cancer	4.03e-05	0.000197	CcSEcCtD
Bromocriptine—Infection—Doxorubicin—breast cancer	4.02e-05	0.000197	CcSEcCtD
Bromocriptine—Vomiting—Capecitabine—breast cancer	3.99e-05	0.000195	CcSEcCtD
Bromocriptine—Shock—Doxorubicin—breast cancer	3.98e-05	0.000195	CcSEcCtD
Bromocriptine—Nervous system disorder—Doxorubicin—breast cancer	3.97e-05	0.000194	CcSEcCtD
Bromocriptine—Rash—Capecitabine—breast cancer	3.96e-05	0.000194	CcSEcCtD
Bromocriptine—Insomnia—Epirubicin—breast cancer	3.95e-05	0.000193	CcSEcCtD
Bromocriptine—Dermatitis—Capecitabine—breast cancer	3.95e-05	0.000193	CcSEcCtD
Bromocriptine—Tachycardia—Doxorubicin—breast cancer	3.95e-05	0.000193	CcSEcCtD
Bromocriptine—Headache—Capecitabine—breast cancer	3.93e-05	0.000192	CcSEcCtD
Bromocriptine—Skin disorder—Doxorubicin—breast cancer	3.93e-05	0.000192	CcSEcCtD
Bromocriptine—Paraesthesia—Epirubicin—breast cancer	3.92e-05	0.000192	CcSEcCtD
Bromocriptine—Dyspnoea—Epirubicin—breast cancer	3.9e-05	0.000191	CcSEcCtD
Bromocriptine—Somnolence—Epirubicin—breast cancer	3.89e-05	0.00019	CcSEcCtD
Bromocriptine—Anorexia—Doxorubicin—breast cancer	3.86e-05	0.000189	CcSEcCtD
Bromocriptine—Nausea—Docetaxel—breast cancer	3.85e-05	0.000188	CcSEcCtD
Bromocriptine—Feeling abnormal—Methotrexate—breast cancer	3.85e-05	0.000188	CcSEcCtD
Bromocriptine—Dyspepsia—Epirubicin—breast cancer	3.85e-05	0.000188	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Methotrexate—breast cancer	3.82e-05	0.000187	CcSEcCtD
Bromocriptine—Decreased appetite—Epirubicin—breast cancer	3.8e-05	0.000186	CcSEcCtD
Bromocriptine—Hypotension—Doxorubicin—breast cancer	3.78e-05	0.000185	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Epirubicin—breast cancer	3.77e-05	0.000185	CcSEcCtD
Bromocriptine—Fatigue—Epirubicin—breast cancer	3.77e-05	0.000184	CcSEcCtD
Bromocriptine—Constipation—Epirubicin—breast cancer	3.74e-05	0.000183	CcSEcCtD
Bromocriptine—Nausea—Capecitabine—breast cancer	3.73e-05	0.000182	CcSEcCtD
Bromocriptine—Urticaria—Methotrexate—breast cancer	3.71e-05	0.000182	CcSEcCtD
Bromocriptine—Abdominal pain—Methotrexate—breast cancer	3.69e-05	0.000181	CcSEcCtD
Bromocriptine—Body temperature increased—Methotrexate—breast cancer	3.69e-05	0.000181	CcSEcCtD
Bromocriptine—Insomnia—Doxorubicin—breast cancer	3.66e-05	0.000179	CcSEcCtD
Bromocriptine—Paraesthesia—Doxorubicin—breast cancer	3.63e-05	0.000178	CcSEcCtD
Bromocriptine—Dyspnoea—Doxorubicin—breast cancer	3.61e-05	0.000176	CcSEcCtD
Bromocriptine—Feeling abnormal—Epirubicin—breast cancer	3.6e-05	0.000176	CcSEcCtD
Bromocriptine—Somnolence—Doxorubicin—breast cancer	3.6e-05	0.000176	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Epirubicin—breast cancer	3.57e-05	0.000175	CcSEcCtD
Bromocriptine—Dyspepsia—Doxorubicin—breast cancer	3.56e-05	0.000174	CcSEcCtD
Bromocriptine—Decreased appetite—Doxorubicin—breast cancer	3.52e-05	0.000172	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Doxorubicin—breast cancer	3.49e-05	0.000171	CcSEcCtD
Bromocriptine—Fatigue—Doxorubicin—breast cancer	3.49e-05	0.000171	CcSEcCtD
Bromocriptine—Urticaria—Epirubicin—breast cancer	3.47e-05	0.00017	CcSEcCtD
Bromocriptine—Constipation—Doxorubicin—breast cancer	3.46e-05	0.000169	CcSEcCtD
Bromocriptine—Body temperature increased—Epirubicin—breast cancer	3.46e-05	0.000169	CcSEcCtD
Bromocriptine—Abdominal pain—Epirubicin—breast cancer	3.46e-05	0.000169	CcSEcCtD
Bromocriptine—Asthenia—Methotrexate—breast cancer	3.35e-05	0.000164	CcSEcCtD
Bromocriptine—Feeling abnormal—Doxorubicin—breast cancer	3.33e-05	0.000163	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Doxorubicin—breast cancer	3.31e-05	0.000162	CcSEcCtD
Bromocriptine—Urticaria—Doxorubicin—breast cancer	3.21e-05	0.000157	CcSEcCtD
Bromocriptine—Abdominal pain—Doxorubicin—breast cancer	3.2e-05	0.000156	CcSEcCtD
Bromocriptine—Body temperature increased—Doxorubicin—breast cancer	3.2e-05	0.000156	CcSEcCtD
Bromocriptine—Diarrhoea—Methotrexate—breast cancer	3.2e-05	0.000156	CcSEcCtD
Bromocriptine—Asthenia—Epirubicin—breast cancer	3.14e-05	0.000153	CcSEcCtD
Bromocriptine—Dizziness—Methotrexate—breast cancer	3.09e-05	0.000151	CcSEcCtD
Bromocriptine—Diarrhoea—Epirubicin—breast cancer	2.99e-05	0.000146	CcSEcCtD
Bromocriptine—Vomiting—Methotrexate—breast cancer	2.97e-05	0.000145	CcSEcCtD
Bromocriptine—Rash—Methotrexate—breast cancer	2.94e-05	0.000144	CcSEcCtD
Bromocriptine—Dermatitis—Methotrexate—breast cancer	2.94e-05	0.000144	CcSEcCtD
Bromocriptine—Headache—Methotrexate—breast cancer	2.93e-05	0.000143	CcSEcCtD
Bromocriptine—Asthenia—Doxorubicin—breast cancer	2.9e-05	0.000142	CcSEcCtD
Bromocriptine—Dizziness—Epirubicin—breast cancer	2.89e-05	0.000141	CcSEcCtD
Bromocriptine—Vomiting—Epirubicin—breast cancer	2.78e-05	0.000136	CcSEcCtD
Bromocriptine—Nausea—Methotrexate—breast cancer	2.77e-05	0.000136	CcSEcCtD
Bromocriptine—Diarrhoea—Doxorubicin—breast cancer	2.77e-05	0.000135	CcSEcCtD
Bromocriptine—Rash—Epirubicin—breast cancer	2.76e-05	0.000135	CcSEcCtD
Bromocriptine—Dermatitis—Epirubicin—breast cancer	2.75e-05	0.000135	CcSEcCtD
Bromocriptine—Headache—Epirubicin—breast cancer	2.74e-05	0.000134	CcSEcCtD
Bromocriptine—Dizziness—Doxorubicin—breast cancer	2.67e-05	0.000131	CcSEcCtD
Bromocriptine—Nausea—Epirubicin—breast cancer	2.6e-05	0.000127	CcSEcCtD
Bromocriptine—Vomiting—Doxorubicin—breast cancer	2.57e-05	0.000126	CcSEcCtD
Bromocriptine—Rash—Doxorubicin—breast cancer	2.55e-05	0.000125	CcSEcCtD
Bromocriptine—Dermatitis—Doxorubicin—breast cancer	2.55e-05	0.000125	CcSEcCtD
Bromocriptine—Headache—Doxorubicin—breast cancer	2.53e-05	0.000124	CcSEcCtD
Bromocriptine—Nausea—Doxorubicin—breast cancer	2.4e-05	0.000118	CcSEcCtD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	1.83e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—JUN—breast cancer	1.82e-06	1.46e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—breast cancer	1.81e-06	1.45e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CTNNB1—breast cancer	1.81e-06	1.45e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—breast cancer	1.81e-06	1.45e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—breast cancer	1.81e-06	1.45e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—breast cancer	1.81e-06	1.45e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SRC—breast cancer	1.8e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—breast cancer	1.8e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCND1—breast cancer	1.8e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—breast cancer	1.8e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—breast cancer	1.8e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.79e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—JUN—breast cancer	1.79e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—KRAS—breast cancer	1.79e-06	1.44e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—COMT—breast cancer	1.79e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—breast cancer	1.79e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CTNNB1—breast cancer	1.78e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTP1—breast cancer	1.78e-06	1.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MAPK3—breast cancer	1.78e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SRC—breast cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—breast cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—HRAS—breast cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—breast cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—KRAS—breast cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—KRAS—breast cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—HRAS—breast cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.77e-06	1.42e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PTEN—breast cancer	1.76e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCND1—breast cancer	1.76e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—HRAS—breast cancer	1.76e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—JUN—breast cancer	1.76e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—HMOX1—breast cancer	1.76e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.76e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—breast cancer	1.76e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ITPR1—breast cancer	1.75e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PIK3CA—breast cancer	1.75e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—breast cancer	1.75e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—breast cancer	1.75e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.74e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	1.74e-06	1.4e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFB1—breast cancer	1.74e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CDKN1A—breast cancer	1.74e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—breast cancer	1.74e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PTEN—breast cancer	1.74e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CD—breast cancer	1.73e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—breast cancer	1.73e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CAV1—breast cancer	1.73e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	1.73e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK8—breast cancer	1.73e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFB1—breast cancer	1.73e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—HRAS—breast cancer	1.72e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—breast cancer	1.72e-06	1.38e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAPK3—breast cancer	1.72e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.72e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—breast cancer	1.71e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—breast cancer	1.71e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—breast cancer	1.71e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAPK3—breast cancer	1.71e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—breast cancer	1.71e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	1.7e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PTEN—breast cancer	1.7e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK8—breast cancer	1.7e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.7e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—breast cancer	1.7e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—HRAS—breast cancer	1.69e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—breast cancer	1.69e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.69e-06	1.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—breast cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ABCB1—breast cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—breast cancer	1.68e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.68e-06	1.35e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—breast cancer	1.68e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.67e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—breast cancer	1.67e-06	1.34e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.67e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.66e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.66e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—breast cancer	1.66e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.66e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.66e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—TYMS—breast cancer	1.66e-06	1.33e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.65e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PIK3CA—breast cancer	1.65e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—breast cancer	1.65e-06	1.32e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PIK3CA—breast cancer	1.64e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—NOS3—breast cancer	1.64e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NCOR1—breast cancer	1.64e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTM1—breast cancer	1.64e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.64e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.64e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SRC—breast cancer	1.64e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.63e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—breast cancer	1.63e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—JUN—breast cancer	1.63e-06	1.31e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	1.63e-06	1.3e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PIK3CA—breast cancer	1.63e-06	1.3e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—breast cancer	1.62e-06	1.3e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—breast cancer	1.62e-06	1.3e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.62e-06	1.3e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—HRAS—breast cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—breast cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—KRAS—breast cancer	1.61e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1.61e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SRC—breast cancer	1.61e-06	1.29e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—KRAS—breast cancer	1.6e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—breast cancer	1.59e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—breast cancer	1.59e-06	1.28e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—breast cancer	1.59e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.59e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1.59e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.58e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—breast cancer	1.58e-06	1.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.58e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—breast cancer	1.58e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SRC—breast cancer	1.58e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CG—breast cancer	1.57e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—breast cancer	1.57e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—breast cancer	1.57e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.57e-06	1.26e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GPX1—breast cancer	1.57e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—breast cancer	1.56e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—breast cancer	1.56e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—breast cancer	1.56e-06	1.25e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—breast cancer	1.55e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—breast cancer	1.55e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.55e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—breast cancer	1.55e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.54e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—KRAS—breast cancer	1.54e-06	1.24e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.54e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ERCC2—breast cancer	1.54e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1.54e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—KRAS—breast cancer	1.53e-06	1.23e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—HRAS—breast cancer	1.53e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—breast cancer	1.52e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—breast cancer	1.52e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CB—breast cancer	1.51e-06	1.21e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK3—breast cancer	1.51e-06	1.21e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—HRAS—breast cancer	1.5e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—HRAS—breast cancer	1.5e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—breast cancer	1.5e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—breast cancer	1.5e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—KRAS—breast cancer	1.49e-06	1.2e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.48e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PIK3CA—breast cancer	1.48e-06	1.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—KRAS—breast cancer	1.47e-06	1.18e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	1.47e-06	1.18e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—breast cancer	1.47e-06	1.17e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SRC—breast cancer	1.46e-06	1.17e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFB1—breast cancer	1.46e-06	1.17e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—breast cancer	1.46e-06	1.17e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	1.45e-06	1.16e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—MTHFR—breast cancer	1.45e-06	1.16e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—breast cancer	1.44e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—breast cancer	1.44e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—breast cancer	1.44e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.44e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—breast cancer	1.43e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—breast cancer	1.43e-06	1.15e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—breast cancer	1.43e-06	1.14e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.43e-06	1.14e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—breast cancer	1.42e-06	1.14e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.42e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—breast cancer	1.41e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.41e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—breast cancer	1.41e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.41e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	1.41e-06	1.13e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CD—breast cancer	1.38e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—breast cancer	1.38e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	1.37e-06	1.1e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—breast cancer	1.37e-06	1.1e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—HRAS—breast cancer	1.37e-06	1.1e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—breast cancer	1.37e-06	1.09e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—breast cancer	1.36e-06	1.09e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—HRAS—breast cancer	1.36e-06	1.09e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—KRAS—breast cancer	1.35e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	1.35e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.35e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—breast cancer	1.35e-06	1.08e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—breast cancer	1.34e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CAV1—breast cancer	1.33e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—KRAS—breast cancer	1.33e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PIK3CA—breast cancer	1.33e-06	1.07e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—breast cancer	1.33e-06	1.06e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—breast cancer	1.33e-06	1.06e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—breast cancer	1.33e-06	1.06e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—breast cancer	1.31e-06	1.05e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—breast cancer	1.31e-06	1.05e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—HRAS—breast cancer	1.31e-06	1.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	1.31e-06	1.05e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—NOS3—breast cancer	1.31e-06	1.05e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTEN—breast cancer	1.31e-06	1.05e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—breast cancer	1.31e-06	1.05e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—KRAS—breast cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—HRAS—breast cancer	1.3e-06	1.04e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—breast cancer	1.3e-06	1.04e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—breast cancer	1.28e-06	1.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—HRAS—breast cancer	1.27e-06	1.02e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—breast cancer	1.26e-06	1e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—HRAS—breast cancer	1.25e-06	1e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—breast cancer	1.25e-06	1e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.24e-06	9.96e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.22e-06	9.8e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.22e-06	9.73e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—breast cancer	1.21e-06	9.72e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.21e-06	9.71e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—breast cancer	1.21e-06	9.69e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CB—breast cancer	1.21e-06	9.66e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—breast cancer	1.2e-06	9.64e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—breast cancer	1.2e-06	9.6e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	1.2e-06	9.6e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—breast cancer	1.2e-06	9.57e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—breast cancer	1.2e-06	9.57e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—breast cancer	1.18e-06	9.48e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—breast cancer	1.16e-06	9.29e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—breast cancer	1.16e-06	9.27e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—breast cancer	1.15e-06	9.22e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HRAS—breast cancer	1.15e-06	9.22e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—HRAS—breast cancer	1.13e-06	9.07e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—breast cancer	1.12e-06	8.97e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.11e-06	8.92e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HRAS—breast cancer	1.11e-06	8.88e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—breast cancer	1.1e-06	8.83e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—breast cancer	1.1e-06	8.82e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—breast cancer	1.09e-06	8.71e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—breast cancer	1.08e-06	8.68e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—breast cancer	1.08e-06	8.63e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.07e-06	8.55e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—breast cancer	1.06e-06	8.5e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—breast cancer	1.05e-06	8.44e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTEN—breast cancer	1.04e-06	8.35e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HRAS—breast cancer	1.03e-06	8.25e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—breast cancer	1.02e-06	8.14e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NOS3—breast cancer	1.01e-06	8.08e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—breast cancer	1e-06	8.01e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—breast cancer	9.87e-07	7.9e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—breast cancer	9.8e-07	7.84e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CB—breast cancer	9.31e-07	7.45e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—breast cancer	9.23e-07	7.39e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CA—breast cancer	9.21e-07	7.38e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—breast cancer	9.1e-07	7.29e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTEN—breast cancer	8.05e-07	6.44e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—breast cancer	7.53e-07	6.03e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CA—breast cancer	7.36e-07	5.89e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—breast cancer	6.01e-07	4.81e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CA—breast cancer	5.68e-07	4.54e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—breast cancer	4.64e-07	3.71e-06	CbGpPWpGaD
